Brief: Relay Therapeutics Q4 Net Income USD -54.889 Million Vs. IBES Estimate USD -68.1 Million
26/02/2026 21:05
Feb 26 (Reuters) - Relay Therapeutics Q4 revenue USD 7 million vs. IBES estimate USD 4.97 million. Q4 basic EPS USD -0.32 Q4 operating expenses USD 67.63 million Q4 operating income USD -60.63 million Q4 EPS USD -0.32
Recent news on Relay Therapeutics
See all newsBrief: X-Chem Announces Phase 3 Milestone In Collaboration With Relay Therapeutics
Relay Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Relay Therapeutics Q2 revenue misses estimates on higher R&D expenses; net loss widens
Brief: Relay Therapeutics Q2 Net Income USD -83.707 Million Vs. IBES Estimate USD -74.2 Million
U.S. RESEARCH ROUNDUP- Alliant Energy, Prog Holdings, Travelers